Efficacy of recombinant erythropoietin for the late treatment of anemia of prematurity in a level IV neonatal intensive care unit: a retrospective single-center cohort study.

Jillian M ConnollyJacquelyn D McClaryRiddhi DesaiAnupama SundaramMandy NeudeckerMary L Nock Rita M Ryan Jaime L Marasch

Published in: Journal of perinatology : official journal of the California Perinatal Association (2024)

Erythropoietin is safe and effective at treating anemia of prematurity as evidenced by a clinically and statistically significant increase in Hct from baseline.

Keyphrases

preterm infants
chronic kidney disease
iron deficiency
low birth weight
recombinant human
signaling pathway
cell proliferation
combination therapy
replacement therapy